Dermapharm AG

7 trials 6 recruiting Commercial sponsor

Filter these 7 trials by condition, phase, country and more.

Open in Search →

7 Registered trials

6 Recruiting

1 Completed trials

1 Countries active

4 Unique IMPs

100% Results reported

Phase III

Phase I (Other)

Phase III: 6 Phase I (Other): 1

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Papulopustular rosacea 1

Top IMPs

METHYLPREDNISOLONE ACEPONATE 2 BETAMETHASONE DIPROPIONATE, CLOTRIMAZOLE 1 CLINDAMYCIN, TRETINOIN 1 IVERMECTIN 1

All trials

7 total

A clinical study comparing the efficacy and safety of a new cream containing ivermectin with the efficacy and safety of the originator produ… Recruiting

2023-505897-13-00 Phase III 1 country IVERMECTIN
Evaluation of the efficacy and safety of a new gel containing 10 mg/g Clindamycin and 0.25 mg/g Tretinoin vs. the originator Acnatac(R) 10 m… Recruiting

2023-504552-10-01 Phase III 1 country CLINDAMYCIN, TRETINOIN
Clinical study to compare two cutaneous creams with the active substance methylprednisolone aceponate 0.1% and one cutaneous cream without a… Recruiting

2024-511390-30-00 Phase III 1 country METHYLPREDNISOLONE ACEPONATE
Clinical study to compare the therapeutic effects of two ointments with the active substances clotrimazole and betamethasone dipropionate an… Recruiting

2022-501415-14-00 Phase III 1 country BETAMETHASONE DIPROPIONATE, CLOTRIMAZOLE
Double-blind, randomised clinical study comparing efficacy and safety of Mecloderm® Cream (Test) vs. Lotricomb® Cream (Reference) vs. Vehicl… Recruiting

2024-514364-54-00 Phase III 1 country
Clinical study to compare two cutaneous ointments with the active substance methylprednisolone aceponate 0.1% and one cutaneous ointment wit… Recruiting

2024-514548-10-01 Phase I (Other) 1 country METHYLPREDNISOLONE ACEPONATE
Clinical study to compare the therapeutic effects of two ointments with active substances betamethasone dipropionate and salicylic acid and … Ended

2024-514788-24-00 Phase III 1 country

Showing 1–7 of 7 trials

← All sponsors A–Z